Abeona Therapeutics ABEO
NASDAQ ABEO
$5.96 +0.03 (+0.51%)
As of: Sep 4, 2026 · 3:20 PM EDT

Abeona Therapeutics (ABEO) Other Non Operating Income (2011 - 2014)

Abeona Therapeutics (ABEO) posted quarterly Other Non Operating Income of -$11.3 million for Q4 2014, down 37.8% year-over-year from -$18.2 million in Q4 2013, and down 1514.29% quarter-over-quarter from -$700000.0 in Q3 2014.

Analysis

Abeona Therapeutics (ABEO) Other Non Operating Income (2011 - 2014) Analysis & Trends

Abeona Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$11.3 million for Q4 2014.

  • In Q4 2014, Other Non Operating Income fell 37.8% year-over-year to -$11.3 million; the TTM figure through Sep 2015 stood at -$11.3 million (up 43.53% YoY), while the FY2025 annual figure was $141000.0, changed N/A from the prior year.
  • Other Non Operating Income for Q4 2014 stood at -$11.3 million, down from -$700000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $33.8 million in Q4 2012, with the low at -$13.9 million in Q3 2012.
  • The 4-year median for Other Non Operating Income is $299500.0 (2012), against an average of -$239437.5.
  • Peak annual rise in Other Non Operating Income reached 1876.03% in 2012, while the deepest fall reached 1321.44% in 2012.
  • Abeona Therapeutics' Other Non Operating Income stood at -$1.9 million in 2011, then surged by 1876.03% to $33.8 million in 2012, then plunged by 124.27% to -$8.2 million in 2013, then tumbled by 37.8% to -$11.3 million in 2014.
  • Business Quant data shows ABEO's Other Non Operating Income at -$11.3 million in Q4 2014, -$700000.0 in Q3 2014, and -$11.7 million in Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Abeona Therapeutics 339.72 Mn 192.90 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -11.30 Mn
Sep 30, 2014 -700,000.00
Jun 30, 2014 -11.69 Mn
Mar 31, 2014 583,000.00
Dec 31, 2013 -461,000.00
Sep 30, 2013 421,000.00
Jun 30, 2013 3.27 Mn
Mar 31, 2013 4.78 Mn
Dec 31, 2012 21.00 Mn
Sep 30, 2012 -13.90 Mn
Jun 30, 2012 -9.41 Mn
Mar 31, 2012 -2.46 Mn
Dec 31, 2011 268,000.00
Sep 30, 2011 1.14 Mn
Jun 30, 2011 939,000.00
Mar 31, 2011 1.24 Mn